Bioactivty and controlled release studies of ranibizumab from polymeric carriers
Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in developed societies. Ranibizumab is an anti-angiogenic agent commonly prescribed to treat AMD. However several issues associated with its frequent intravitreal injections have intensified the need for a sustaine...
Saved in:
Main Author: | Chua, Hui Yee |
---|---|
Other Authors: | Subbu S. Venkatraman |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2018
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/73341 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Formulation and in-vitro release studies of Ranibizumab (Lucentis) loaded liposomes
by: Ang, Jin Yan
Published: (2013) -
Controlled drug release from multi-phase polymeric particles
by: Lee, Wei Li
Published: (2012) -
Release studies of naked DNA, polyplexes and lipoplexes from polymeric films
by: Ramgopal Yamini
Published: (2008) -
Engineering of erythrocyte-based drug carriers : control of protein release and bioactivity
by: Luo, Rongcong, et al.
Published: (2013) -
Development and drug release characterization of biodegradable polymeric ocular implants
by: Ho, Joey Sok Kuan.
Published: (2008)